AGENUS INC — Director's Dealing 2017

Jul 7, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2017-06-29

Reporting Person: Duncan Alex (Chief Technology Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14149	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option, right to buy	$4.11	2025-01-08	Common Stock (150000)		Direct
Restricted Stock Unit	$0	2019-03-31	Common Stock (13500)		Direct
Stock Option, right to buy	$4.16	2026-03-31	Common Stock (80000)		Direct
Stock Option, right to buy	$3.77	2027-03-31	Common Stock (162500)		Direct

Footnotes

F1: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests in four annual installments from January 8, 2015, the date of grant.

F2: Award granted in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and is eligible to vest in a single installment on March 31, 2019 based on Company stock price performance. Amount shown reflects the target award. The ultimate award size can range between 50% and 150% of the target based on the actual average stock price achieved.

F3: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests over three years with one-third vested on March 31, 2017 and the balance in equal quarterly installments thereafter.

F4: Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests one-third on the one-year anniversary of the grant date, March 31, 2017, with the balance vesting in equal quarterly installments thereafter.